Back
4D Molecular Therapeutics Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Buy
53
FDMT
4D Molecular Therapeutics
Last Price:
26.82
Seasonality Move:
-18.33%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing slight buying pressure.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.98 | Buy |
| 20-day SMA: | 25.59 | Buy |
| 50-day SMA: | 28.33 | Sell |
| 200-day SMA: | 19.4 | Buy |
| 8-day EMA: | 25.64 | Buy |
| 20-day EMA: | 26.05 | Buy |
| 50-day EMA: | 26.51 | Buy |
| 200-day EMA: | 21.75 | Buy |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 51.64 | Buy |
| Chaikin Money Flow: | 39384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
4D Molecular Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 26.74 while FDMT 8-day simple moving average is 24.98, which is a Buy signal.
- The stock price of FDMT is 26.74 while 4D Molecular Therapeutics 20-day SMA is 25.59, which makes it a Buy.
- 4D Molecular Therapeutics 50-day simple moving average is 28.33 while FDMT share price is 26.74, making it a Sell technically.
- FDMT stock price is 26.74 and 4D Molecular Therapeutics 200-day simple moving average is 19.40, creating a Buy signal.
FDMT Technical Analysis vs Fundamental Analysis
Buy
53
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a Buy
The current 4D Molecular Therapeutics [FDMT] share price is $26.74. The Score for FDMT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
1.33B
Price in USD:
26.74
Share Volume:
331.95K
4D Molecular Therapeutics 52-Week Range
52-Week High:
36.25
52-Week Low:
9.44
Buy
53
4D Molecular Therapeutics (FDMT)
is a Buy
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?
The 4D Molecular Therapeutics stock price is 26.74 USD today. -
Will FDMT stock go up or go down?
4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is 4D Molecular Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is not overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 26.74 while FDMT 8-day exponential moving average is 25.64, which is a Buy signal.
- The stock price of FDMT is 26.74 while 4D Molecular Therapeutics 20-day EMA is 26.05, which makes it a Buy.
- 4D Molecular Therapeutics 50-day exponential moving average is 26.51 while FDMT share price is 26.74, making it a Buy technically.
- FDMT stock price is 26.74 and 4D Molecular Therapeutics 200-day simple moving average is 21.75, creating a Buy signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
- FDMT Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting 4D Molecular Therapeutics is a Sell
- 4D Molecular Therapeutics Relative Strength Index (RSI) is 51.64, which suggest 4D Molecular Therapeutics is overbought
- The Bollinger Bands (25) for 4D Molecular Therapeutics is ( - ), which suggest 4D Molecular Therapeutics is a Buy
- The Bollinger Bands (100) for 4D Molecular Therapeutics is ( - ), which suggest 4D Molecular Therapeutics is a Buy
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.